Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Prapotnich

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Actas Urologicas Espanolas|March 13, 2019
Oncological outcomes and pathological characteristics of cT1 upstaging to pT3a renal cell carcinoma compared with de novo pT3a tumorsV Senguttuvan Karthikeyan, A Mallya, A Sivaraman, et al.
International Journal of Cancer|May 16, 1997
MHC-dependent cytolysis of autologous tumor cells by lymphocytes infiltrating urothelial carcinomasF Housseau, D Zeliszewski, M Roy, et al.
Actas Urologicas Espanolas|August 21, 2016
High intensity focused ultrasound with Focal-One<sup>®</sup> device: Prostate-specific antigen impact and morbidity evaluation during the initial experienceJ I Perez-Reggeti, R Sanchez-Salas, A Sivaraman, et al.
British Journal of Cancer|August 14, 2003
Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001)A Villers, P Pommier, A Bataillard, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Actas Urologicas Espanolas|March 13, 2019
Oncological outcomes and pathological characteristics of cT1 upstaging to pT3a renal cell carcinoma compared with de novo pT3a tumorsV Senguttuvan Karthikeyan, A Mallya, A Sivaraman, et al.
International Journal of Cancer|May 16, 1997
MHC-dependent cytolysis of autologous tumor cells by lymphocytes infiltrating urothelial carcinomasF Housseau, D Zeliszewski, M Roy, et al.
Actas Urologicas Espanolas|August 21, 2016
High intensity focused ultrasound with Focal-One<sup>®</sup> device: Prostate-specific antigen impact and morbidity evaluation during the initial experienceJ I Perez-Reggeti, R Sanchez-Salas, A Sivaraman, et al.
British Journal of Cancer|August 14, 2003
Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001)A Villers, P Pommier, A Bataillard, et al.
Pageof 3